These include thymocyte selection-associated high-mobility-box proteins (TOX), members of the activated T-cell family of nuclear factors, and transcription factors of nuclear receptor subfamily four and group a, all of which contribute to increased expression of LAG-3 (94–96), which tends to lead to tumor progression and a poor prognosis. The gene discussed is LAG3; the disease is neoplasm.